NCT Number: NCT00000414
Patient Education in Rheumatoid Arthritis and Osteoarthritis
This project will evaluate the effectiveness and general usefulness of two arthritis patient education programs. The first, the Arthritis Self-Management Program, is a 6-week, community-based program taught in small groups by peer leaders. The second, the Self-Managed Arthritis Relief Therapy (SMART) Program, is a computer-driven program delivered through the mail. Participants in this project are people with rheumatoid arthritis or osteoarthritis who are taking part in the larger long-term studies being conducted by ARAMIS (the Arthritis, Rheumatism and Aging Medical Information System).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
University of Saskatoon, Edmonton, Alberta, Canada
About this study
In a changing health care environment, the role of patients in managing their arthritis is increasingly important. Patient education is the primary means for teaching patients how to fulfill this role successfully. The goal of self-management health education is not merely to provide information but also to change patient attitudes and behavior so that patient outcomes are improved. These programs represent a new treatment for arthritis.
This project will evaluate the relative effect on health status and cost-effectiveness of two arthritis patient education programs that use different delivery systems. The Arthritis Self-Management Program (ASMP) uses a small group, multi-class format. It is taught by trained lay leaders and has been evaluated for effectiveness and widely disseminated. The Self-Managed Arthritis Relief Therapy (SMART) Program is a computer-driven, individualized, mail-delivered intervention. Results of a pilot study suggest that it is effective in improving health status and reducing health care use.
The project will also evaluate how generalizable the SMART program is and its effectiveness for patients with different diagnoses (OA and RA). It will also determine the attributes of patients who choose and do not choose to participate in patient education programs as well as the attributes of those who complete and do not complete the ASMP and SMART programs.
Through use of the ARAMIS data collection system, the project allows us to describe the differences between people who volunteer to receive patient education and those who refuse patient education. This project is directed at improving patient outcomes in both RA and OA through wide availability of a low-cost, mail-delivered arthritis self-management program that is the next generation in arthritis health education.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Physician diagnosis of OA or RA
- Participation in the ARAMIS longitudinal study
Exclusion criteria
- Age under 18
Treatment and study plan
SMART Program
BehavioralOther names: Self-Managed Arthritis Relief Therapy (SMART)
Sponsors and collaborators
Lead sponsor
Stanford University
Other
Collaborators
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Registry information
Official study title
Patient Education Strategies for Better Outcomes in Rheumatoid Arthritis (RA) and Osteoarthritis (OA)
Important dates
- Study start
- 1996
- Primary completion
- 2001
- Study completion
- 2001
- First posted
- Nov 4, 1999
- Registry last updated
- Jun 21, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Role of ASICs in Human Inflammatory Pain
NCT01867840
Arthritis, Arthritis, Gouty
Nice, France
View Trial DetailsSidus(TM) Post Market Clinical Follow-up (PMCF) Study
NCT01700543
Arthritis, Arthritis, Rheumatoid
Linz, Austria
View Trial DetailsPhone-Based Based Walk With Ease Program for Adults With Arthritis
NCT05289544
Arthritis, Arthritis, Rheumatoid
Columbia, South Carolina, United States
View Trial DetailsVitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
NCT01351805
Arthritis, Arthritis, Rheumatoid
Boston, Massachusetts, United States
View Trial Details